Covid-19, Acute Myocardial Infarctions and Strokes in France

NCT04542083 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 911

Last updated 2023-08-16

No results posted yet for this study

Summary

The COVID-19 pandemic has had dramatic effects on health systems and on non-COVID health care.

Using French inpatient claims data and retrospectively collected clinical data, the investigators will assess the changes in hospital admissions for acute cardiovascular and neurovascular conditions in France during and after the national lockdown.

Conditions

  • COVID-19
  • Acute Cardiovascular Condition
  • Acute Neurovascular Condition
  • Stroke
  • Acute Myocardial Infarction

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Grégoire Mercier, PU PH · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-20
Primary Completion
2023-07-25
Completion
2023-07-25

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04542083 on ClinicalTrials.gov